| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Robert A. OrtenzioChairman of the Board | -130.00k | 3.25M | 売り | 25.00 | 8.01M | -1.60% |
| 2026-05-08 | Mr. Robert A. OrtenzioChairman of the Board | -130.00k | 3.25M | 売り | 25.00 | 8.14M | -1.57% |
| 2025-12-17 | Mr. William Keith NewtonCEO & Director | -89.08k | 0.00 | Other Disposition | - | 482.83k | -15.58% |
| 2025-11-26 | Mr. Michael D. RhineExec. VP, COO of Onsite Health & Telemedicine | -3.94k | 82.79k | Sale to Issuer | 21.04 | 76.16k | -4.91% |
| 2025-11-26 | Mr. Timothy F. RyanExec. VP & Chief Legal Counsel | -5.90k | 124.20k | Sale to Issuer | 21.04 | - | - |
| 2025-11-26 | Ms. Su Zan NelsonExec. VP & CAO | -5.90k | 124.20k | Sale to Issuer | 21.04 | 114.10k | -4.92% |
| 2025-11-26 | Mr. Douglas R. McAndrewExec. VP & COO of West | -5.90k | 124.20k | Sale to Issuer | 21.04 | 114.10k | -4.92% |
| 2025-11-26 | Mr. Michael A. KosuthExec. VP & COO of East | -6.45k | 135.69k | Sale to Issuer | 21.04 | 113.55k | -5.37% |
| 2025-11-26 | Ms. Danielle KendallExec. VP & CPO | -3.94k | 82.79k | Sale to Issuer | 21.04 | 76.07k | -4.92% |
| 2025-11-26 | Mr. Gregory M. GilbertExec. VP, Chief Reimbursement & Government Relations Officer | -5.90k | 124.20k | Sale to Issuer | 21.04 | 114.10k | -4.92% |
| 2025-11-26 | Mr. Giovanni GallaraExec. VP & Chief Clinical Services Officer | -6.56k | 138.09k | Sale to Issuer | 21.04 | 113.44k | -5.47% |
| 2025-11-26 | Mr. Matthew T. DiCanioPresident & CFO | -17.71k | 372.58k | Sale to Issuer | 21.04 | 342.29k | -4.92% |
| 2025-11-26 | Mr. Thomas A. DevasiaExec. VP and Chief Marketing & Innovation Officer | -5.90k | 124.20k | Sale to Issuer | 21.04 | 114.10k | -4.92% |
| 2025-11-26 | Mr. John A. deLorimierExec. VP and Chief Information & Technology Officer | -6.43k | 135.25k | Sale to Issuer | 21.04 | 113.57k | -5.36% |
| 2025-11-26 | Mr. Jonathan P. ConserExec. VP and Chief Growth & Customer Officer | -5.90k | 124.20k | Sale to Issuer | 21.04 | 114.10k | -4.92% |
| 2025-11-26 | Dr. John R. AndersonExec. VP & Chief Medical Officer | -6.54k | 137.60k | Sale to Issuer | 21.04 | 113.46k | -5.45% |
| 2025-11-25 | Mr. Robert A. OrtenzioChairman of the Board | -100.00k | 0.00 | Other Disposition | - | 8.17M | -1.21% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。